Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IDH1 anticorps (AA 281-414)

Cet anticorps anti-IDH1 est un anticorps Souris Monoclonal détectant IDH1 dans IHC et StM. Adapté pour Humain.
N° du produit ABIN6939688

Aperçu rapide pour IDH1 anticorps (AA 281-414) (ABIN6939688)

Antigène

Voir toutes IDH1 Anticorps
IDH1 (Isocitrate Dehydrogenase 1 (NADP+), Soluble (IDH1))

Reactivité

  • 112
  • 66
  • 46
  • 8
  • 7
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
Humain

Hôte

  • 86
  • 43
  • 3
  • 1
Souris

Clonalité

  • 82
  • 51
Monoclonal

Conjugué

  • 75
  • 12
  • 9
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp IDH1 est non-conjugé

Application

  • 95
  • 45
  • 33
  • 29
  • 26
  • 23
  • 16
  • 15
  • 13
  • 9
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Staining Methods (StM)

Clone

IDH1-1152
  • Épitope

    • 15
    • 12
    • 10
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 281-414

    Specificité

    It recognizes a 45 kDa protein, which is identified as isocitrate dehydrogenase (IDH1). It belongs to the isocitrate and isopropylmalate dehydrogenases family. IDH1 catalyzes the third step of the citric acid cycle, which involves the oxidative decarboxylation of isocitrate, forming -ketoglutarate. During this process, either NADH or NADPH is produced along with CO2. Recently, an inactivating mutation of IDH1 has been implicated in glioblastoma. IDH1 appears to function as a tumor suppressor that, when mutationally inactivated, contributes to tumorigenesis in part through induction of the HIF-1 pathway.

    Purification

    Purified by Protein A/G

    Immunogène

    Recombinant fragment of human IDH1 protein (around aa 281-414) (exact sequence is proprietary)

    Isotype

    IgG1 kappa
  • Indications d'application

    Positive Control: HepG2, HeLa, HT29 or MCF7 cells. Breast, Colon or Prostate Carcinoma.

    Known Application: Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    IDH1 (Isocitrate Dehydrogenase 1 (NADP+), Soluble (IDH1))

    Autre désignation

    IDH1

    Poids moléculaire

    45-47kDa

    ID gène

    3417

    UniProt

    O75874

    Pathways

    L'effet Warburg
Vous êtes ici:
Chat with us!